Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
CLOXACILLIN
(1974)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
CLOXACILLIN
×
Maximum Phase:
4
First Approval:
1974
UNII:
O6X5QGC2VB
Molecule Type:
Small molecule
Molecular Formula:
C19H18ClN3O5S
Molecular Weight:
435.89
AlogP:
2.55
PSA:
112.74
HBD:
2.0
HBA:
#RotB:
4.0
Source:
CYCLOPENTOLATE HYDROCHLORIDE
(1974)
Small molecule
Muscarinic acetylcholine receptor M3 antagonist
OPHTHALMIC
Approved
Mydriasis
CYCLOPENTOLATE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1974
UNII:
736I6971TE
Molecule Type:
Small molecule
Molecular Formula:
C17H26ClNO3
Molecular Weight:
327.85
AlogP:
2.18
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TERBUTALINE
(1974)
Small molecule
Unknown
Unknown
Approved
Lung Diseases, Obstructive
TERBUTALINE
×
Maximum Phase:
4
First Approval:
1974
UNII:
N8ONU3L3PG
Molecule Type:
Small molecule
Molecular Formula:
C12H19NO3
Molecular Weight:
225.29
AlogP:
1.52
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
3.0
Source:
CEPHAPIRIN
(1974)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
CEPHAPIRIN
×
Maximum Phase:
4
First Approval:
1974
UNII:
89B59H32VN
Molecule Type:
Small molecule
Molecular Formula:
C17H17N3O6S2
Molecular Weight:
423.47
AlogP:
0.48
PSA:
125.9
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CLONIDINE HYDROCHLORIDE
(1974)
Small molecule
Adrenergic receptor alpha-2 agonist
INJECTION; ORAL
Approved
Attention Deficit Disorder with Hyperactivity; Hypertension
CLONIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1974
UNII:
W76I6XXF06
Molecule Type:
Small molecule
Molecular Formula:
C9H10Cl3N3
Molecular Weight:
266.56
AlogP:
2.17
PSA:
36.42
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PERHEXILINE
(1974)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
PERHEXILINE
×
Maximum Phase:
4
First Approval:
1974
UNII:
KU65374X44
Molecule Type:
Small molecule
Molecular Formula:
C19H35N
Molecular Weight:
277.5
AlogP:
5.3
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DOPAMINE HYDROCHLORIDE
(1974)
Small molecule
Beta-1 adrenergic receptor agonist
INJECTION
Approved
Heart Failure; Myocardial Infarction; Renal Insufficiency
DOPAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1974
UNII:
7L3E358N9L
Molecule Type:
Small molecule
Molecular Formula:
C8H12ClNO2
Molecular Weight:
189.64
AlogP:
0.6
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
2.0
Source:
AZATHIOPRINE SODIUM
(1974)
Small molecule
Amidophosphoribosyltransferase inhibitor
INJECTION
Approved
Unknown
AZATHIOPRINE SODIUM
×
Maximum Phase:
4
First Approval:
1974
UNII:
AM94R510MS
Molecule Type:
Small molecule
Molecular Formula:
C9H6N7NaO2S
Molecular Weight:
299.25
AlogP:
1.15
PSA:
115.42
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AMOXICILLIN
(1974)
Small molecule
Bacterial penicillin-binding protein inhibitor
ORAL
Approved
Bacterial Infections; Duodenal Ulcer; Gonorrhea; Infections; Otitis Media; Pharyngitis; Pneumonia; Respiratory Tract Infections; Sinusitis; Soft Tissue Infections; Tonsillitis; Urinary Tract Infections
AMOXICILLIN
×
Maximum Phase:
4
First Approval:
1974
UNII:
804826J2HU
Molecule Type:
Small molecule
Molecular Formula:
C16H19N3O5S
Molecular Weight:
365.41
AlogP:
0.02
PSA:
132.96
HBD:
4.0
HBA:
#RotB:
4.0
Source:
DANTROLENE SODIUM
(1974)
Small molecule
Ryanodine receptor 1 antagonist
INJECTION; INTRAVENOUS; ORAL
Approved
Cerebral Palsy; Hyperthermia; Multiple Sclerosis; Muscle Spasticity; Spinal Cord Injuries; Stroke
DANTROLENE SODIUM
×
Maximum Phase:
4
First Approval:
1974
UNII:
287M0347EV
Molecule Type:
Small molecule
Molecular Formula:
C14H9N4NaO5
Molecular Weight:
336.24
AlogP:
1.74
PSA:
118.05
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DANTROLENE
(1974)
Small molecule
Unknown
Unknown
Approved
Unknown
DANTROLENE
×
Maximum Phase:
4
First Approval:
1974
UNII:
F64QU97QCR
Molecule Type:
Small molecule
Molecular Formula:
C14H10N4O5
Molecular Weight:
314.26
AlogP:
1.74
PSA:
118.05
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BENZQUINAMIDE HYDROCHLORIDE
(1974)
Small molecule
Dopamine D2 receptor modulator
INJECTION; RECTAL
Approved
Unknown
BENZQUINAMIDE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1974
UNII:
3221WFM86J
Molecule Type:
Small molecule
Molecular Formula:
C22H33ClN2O5
Molecular Weight:
440.97
AlogP:
2.42
PSA:
68.31
HBD:
0.0
HBA:
#RotB:
6.0
Source:
ISOSORBIDE
(1974)
Small molecule
Unknown
ORAL
Approved
Unknown
ISOSORBIDE
×
Maximum Phase:
4
First Approval:
1974
UNII:
WXR179L51S
Molecule Type:
Small molecule
Molecular Formula:
C6H10O4
Molecular Weight:
146.14
AlogP:
-1.49
PSA:
58.92
HBD:
2.0
HBA:
#RotB:
0.0
Source:
CHROMIC PHOSPHATE P 32
(1974)
Small molecule
Unknown
Unknown
Approved
Unknown
CHROMIC PHOSPHATE P 32
×
Maximum Phase:
4
First Approval:
1974
UNII:
QHO02LZ4H2
Molecule Type:
Small molecule
Molecular Formula:
CrO4P
Molecular Weight:
147.97
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AMPHETAMINE ADIPATE
(1975)
Small molecule
Dopamine transporter releasing agent
Unknown
Approved
Unknown
AMPHETAMINE ADIPATE
×
Maximum Phase:
4
First Approval:
1975
UNII:
Z58RH02W4M
Molecule Type:
Small molecule
Molecular Formula:
C15H23NO4
Molecular Weight:
281.35
AlogP:
1.58
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PSEUDOEPHEDRINE HYDROCHLORIDE
(1975)
Small molecule
Norepinephrine transporter releasing agent
ORAL
Approved
Common Cold; Cough; Hypersensitivity; Influenza, Human; Migraine Disorders; Nasal Obstruction; Pain; Rhinitis, Allergic, Seasonal; Sinusitis
PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1975
UNII:
6V9V2RYJ8N
Molecule Type:
Small molecule
Molecular Formula:
C10H16ClNO
Molecular Weight:
201.7
AlogP:
1.33
PSA:
32.26
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BETAMETHASONE DIPROPIONATE
(1975)
Small molecule
Glucocorticoid receptor agonist
TOPICAL
Approved
Eye Diseases; Hemorrhoids; Infections; Lung Diseases, Obstructive; Nasal Obstruction; Psoriasis; Skin Diseases
BETAMETHASONE DIPROPIONATE
×
Maximum Phase:
4
First Approval:
1975
UNII:
826Y60901U
Molecule Type:
Small molecule
Molecular Formula:
C28H37FO7
Molecular Weight:
504.6
AlogP:
3.82
PSA:
106.97
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ESTRADIOL
(1975)
Small molecule
Estrogen receptor alpha agonist
ORAL; TOPICAL; TRANSDERMAL; VAGINAL
Approved
Dyspareunia; Hypogonadism; Primary Ovarian Insufficiency
ESTRADIOL
×
Maximum Phase:
4
First Approval:
1975
UNII:
4TI98Z838E
Molecule Type:
Small molecule
Molecular Formula:
C18H24O2
Molecular Weight:
272.39
AlogP:
3.61
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
OXYBUTYNIN
(1975)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
TRANSDERMAL
Approved
Polyuria; Urinary Bladder, Overactive; Urinary Incontinence; Urinary Incontinence, Urge
OXYBUTYNIN
×
Maximum Phase:
4
First Approval:
1975
UNII:
K9P6MC7092
Molecule Type:
Small molecule
Molecular Formula:
C22H31NO3
Molecular Weight:
357.49
AlogP:
3.34
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CLOTRIMAZOLE
(1975)
Small molecule
Cytochrome P450 51 inhibitor
ORAL; TOPICAL; VAGINAL
Approved
Candidiasis; Infections; Mycoses; Pruritus; Skin Diseases, Infectious; Tinea; Tinea Pedis; Tinea cruris
CLOTRIMAZOLE
×
Maximum Phase:
4
First Approval:
1975
UNII:
G07GZ97H65
Molecule Type:
Small molecule
Molecular Formula:
C22H17ClN2
Molecular Weight:
344.85
AlogP:
5.38
PSA:
17.82
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TOBRAMYCIN SULFATE
(1975)
Small molecule
70S ribosome inhibitor
INJECTION
Approved
Unknown
TOBRAMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
1975
UNII:
HJT0RXD7JK
Molecule Type:
Small molecule
Molecular Formula:
C36H84N10O38S5
Molecular Weight:
1425.44
AlogP:
-6.3
PSA:
268.17
HBD:
10.0
HBA:
#RotB:
6.0
Source:
CARBIDOPA
(1975)
Small molecule
DOPA decarboxylase inhibitor
ORAL
Approved
Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Wounds and Injuries
CARBIDOPA
×
Maximum Phase:
4
First Approval:
1975
UNII:
MNX7R8C5VO
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4
Molecular Weight:
226.23
AlogP:
-0.05
PSA:
115.81
HBD:
5.0
HBA:
#RotB:
4.0
Source:
OXYBUTYNIN CHLORIDE
(1975)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
ORAL; TRANSDERMAL
Approved
Urinary Bladder, Overactive
OXYBUTYNIN CHLORIDE
×
Maximum Phase:
4
First Approval:
1975
UNII:
L9F3D9RENQ
Molecule Type:
Small molecule
Molecular Formula:
C22H32ClNO3
Molecular Weight:
393.96
AlogP:
3.34
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
7.0
Source:
HYDROXYPROGESTERONE CAPROATE
(1975)
Small molecule
Progesterone receptor agonist
INJECTION; INTRAMUSCULAR; SUBCUTANEOUS
Approved
Premature Birth
HYDROXYPROGESTERONE CAPROATE
×
Maximum Phase:
4
First Approval:
1975
UNII:
276F2O42F5
Molecule Type:
Small molecule
Molecular Formula:
C27H40O4
Molecular Weight:
428.61
AlogP:
5.97
PSA:
60.44
HBD:
0.0
HBA:
#RotB:
6.0
Source:
DEXTROAMPHETAMINE ADIPATE
(1975)
Small molecule
Dopamine transporter releasing agent
Unknown
Approved
Unknown
DEXTROAMPHETAMINE ADIPATE
×
Maximum Phase:
4
First Approval:
1975
UNII:
YYI1A8W4TQ
Molecule Type:
Small molecule
Molecular Formula:
C15H23NO4
Molecular Weight:
281.35
AlogP:
1.58
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LOXAPINE SUCCINATE
(1975)
Small molecule
D2-like dopamine receptor antagonist
ORAL
Approved
Unknown
LOXAPINE SUCCINATE
×
Maximum Phase:
4
First Approval:
1975
UNII:
X59SG0MRYU
Molecule Type:
Small molecule
Molecular Formula:
C22H24ClN3O5
Molecular Weight:
445.9
AlogP:
3.77
PSA:
28.07
HBD:
0.0
HBA:
#RotB:
0.0
Source:
LOXAPINE
(1975)
Small molecule
D2-like dopamine receptor antagonist
Unknown
Approved
Bipolar Disorder; Mental Disorders; Psychomotor Agitation; Psychotic Disorders; Schizophrenia
LOXAPINE
×
Maximum Phase:
4
First Approval:
1975
UNII:
LER583670J
Molecule Type:
Small molecule
Molecular Formula:
C18H18ClN3O
Molecular Weight:
327.81
AlogP:
3.77
PSA:
28.07
HBD:
0.0
HBA:
#RotB:
0.0
Source:
SULFACYTINE
(1975)
Small molecule
Dihydropteroate synthetase inhibitor
ORAL
Approved
Unknown
SULFACYTINE
×
Maximum Phase:
4
First Approval:
1975
UNII:
T795873AJP
Molecule Type:
Small molecule
Molecular Formula:
C12H14N4O3S
Molecular Weight:
294.34
AlogP:
0.65
PSA:
107.08
HBD:
2.0
HBA:
#RotB:
4.0
Source:
DIGOXIN
(1975)
Small molecule
Sodium/potassium-transporting ATPase inhibitor
INJECTION; ORAL
Approved
Atrial Fibrillation; Cardiovascular Diseases; Heart Failure
DIGOXIN
×
Maximum Phase:
4
First Approval:
1975
UNII:
73K4184T59
Molecule Type:
Small molecule
Molecular Formula:
C41H64O14
Molecular Weight:
780.95
AlogP:
2.22
PSA:
203.06
HBD:
6.0
HBA:
#RotB:
7.0
Source:
CLONAZEPAM
(1975)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
ORAL
Approved
Epilepsy; Panic Disorder; Seizures
CLONAZEPAM
×
Maximum Phase:
4
First Approval:
1975
UNII:
5PE9FDE8GB
Molecule Type:
Small molecule
Molecular Formula:
C15H10ClN3O3
Molecular Weight:
315.72
AlogP:
3.04
PSA:
84.6
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TOBRAMYCIN
(1975)
Small molecule
70S ribosome inhibitor
INHALATION; OPHTHALMIC
Approved
Bacterial Infections; Conjunctivitis, Allergic; Cystic Fibrosis; Eye Infections; Infections; Inflammation
TOBRAMYCIN
×
Maximum Phase:
4
First Approval:
1975
UNII:
VZ8RRZ51VK
Molecule Type:
Small molecule
Molecular Formula:
C18H37N5O9
Molecular Weight:
467.52
AlogP:
-6.3
PSA:
268.17
HBD:
10.0
HBA:
#RotB:
6.0
Source:
PEMOLINE
(1975)
Small molecule
Unknown
Unknown
Approved
Attention Deficit Disorder with Hyperactivity
PEMOLINE
×
Maximum Phase:
4
First Approval:
1975
UNII:
7GAQ2332NK
Molecule Type:
Small molecule
Molecular Formula:
C9H8N2O2
Molecular Weight:
176.18
AlogP:
0.6
PSA:
64.68
HBD:
1.0
HBA:
#RotB:
1.0
Source:
DACARBAZINE
(1975)
Small molecule
DNA inhibitor
INJECTION
Approved
Hodgkin Disease; Melanoma; Neoplasms
DACARBAZINE
×
Maximum Phase:
4
First Approval:
1975
UNII:
7GR28W0FJI
Molecule Type:
Small molecule
Molecular Formula:
C6H10N6O
Molecular Weight:
182.19
AlogP:
0.07
PSA:
99.73
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LOMUSTINE
(1976)
Small molecule
DNA inhibitor
ORAL
Approved
Brain Neoplasms; Hodgkin Disease; Neoplasms
LOMUSTINE
×
Maximum Phase:
4
First Approval:
1976
UNII:
7BRF0Z81KG
Molecule Type:
Small molecule
Molecular Formula:
C9H16ClN3O2
Molecular Weight:
233.7
AlogP:
2.25
PSA:
61.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LACTULOSE
(1976)
Small molecule
Colonic bacteria substrate
ORAL; RECTAL
Approved
Constipation
LACTULOSE
×
Maximum Phase:
4
First Approval:
1976
UNII:
9U7D5QH5AE
Molecule Type:
Small molecule
Molecular Formula:
C12H22O11
Molecular Weight:
342.3
AlogP:
-5.4
PSA:
189.53
HBD:
8.0
HBA:
#RotB:
5.0
Source:
FENOPROFEN
(1976)
Small molecule
Unknown
Unknown
Approved
Rheumatic Diseases
FENOPROFEN
×
Maximum Phase:
4
First Approval:
1976
UNII:
RA33EAC7KY
Molecule Type:
Small molecule
Molecular Formula:
C15H14O3
Molecular Weight:
242.27
AlogP:
3.67
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
17
18
19
20
21
22
23
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA